Printer Friendly
The Free Library
14,581,695 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Medis El files for new patents.


TEL AVIV Tel Aviv (tĕl əvēv`), city (1994 pop. 355,200), W central Israel, on the Mediterranean Sea. Oficially named Tel Aviv–Jaffa, it is Israel's commercial, financial, communications, and cultural center and the core of its largest , Israel--(BUSINESS WIRE)--May 9, 1996--Medis El Ltd. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: MDSLF) today announced that it had filed for patents for a synchronous twin reciprocating piston apparatus.

The Medis invention creates a revolutionary linear compressor. It is composed of a piston which moves back and forth on air bearings in a cylinder under the influence of an electromagnetic field electromagnetic field

Property of space caused by the motion of an electric charge. A stationary charge produces an electric field in the surrounding space. If the charge is moving, a magnetic field is also produced. A changing magnetic field also produces an electric field.
 in one direction and a rebalancing Rebalancing

The process of realigning the weightings of one's portfolio of assets.

Notes:
For example, if your portfolio's proportion of stock has grown too large for your intended assets weightings and risk tolerance, you might rebalance by selling some stock and putting
 spring force in another. The linear compressor has only clearance seals and has no rotating parts. As a result, there is minimal dissipation of energy Same as Degradation of energy, under Degradation.

See also: Dissipation
 so that the compressor creates relatively little heat and there is little wear in the system. The compressor is highly efficient and is expected to have a very long life, as much as tens of thousands of hours of maintenance free use. Medis anticipates that its manufacturing cost will be competitive with the cost of making current compressors.

One of the envisaged uses is for cryo-coolers working in the sterling cycle. In that use, the compressor operates using helium, a natural gas found in the atmosphere. It does not require freon or other gases that create environmental problems by depleting the ozone or have a negative greenhouse effect.

"We expect this newly designed product to make a valuable contribution in areas where compressors or pumps are used; for example, in diesel engines, air conditioners and refrigerators," said Robert K. Lifton, chairman of Medis El. "We think it will be particularly important in its ability to create extreme cold, as low as minus 200 degrees Celsius. This makes it valuable for military use in IR systems for missiles, tanks and other applications.

"It is also expected to be useful in creating extreme cold for Cryosurgery cryosurgery (krī`ōsr'jərē), bloodless surgical technique using a supercooled probe to destroy diseased or superfluous tissue.  where the cancerous or benign tumors are frozen in situ In place. When something is "in situ," it is in its original location.  such as in brain, prostate and liver operations. The equipment presently being used is expensive and complex to use and utilizes liquid nitrogen for freezing. A linear sterling cycle cryogenic compressor will enable construction of more efficient and safer equipment. This technology may also be helpful to dermatologists for removing facial and body growths by freezing them."

Medis has built several prototypes of its invention as technology demonstrators. It has designed fully working models which it expects to have ready within five months. The company contemplates manufacturing the compressor for certain applications and licensing the patent for other applications.

Medis El is engaged in developing and using advanced technology in the medical and related fields. In addition to the new compressor, it manufactures the CellScan and the Neuritor. The CellSCan is a multiparameter laser based cytometer which has the unique capacity precisely and repeatedly to measure fluorescence, intensity and polarization of individual living cells and facilitate kinetic analysis in heterogenous (spelling) heterogenous - It's spelled heterogeneous.  cell populations. It is used for physiologic, clinical and diagnostic investigations of cells. The Neuritor is an advanced low cost, digital high quality 16 channel EEG EEG: see electroencephalography.  system which integrates compact design and true portability with the operational features of larger more expensive systems.

CONTACT: Medis El Ltd.

Robert K. Lifton, 212/935-8484
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 9, 1996
Words:506
Previous Article:BAUSCH & LOMB's GENERIC MINOXIDIL IS ON ITS WAY TO MARKET; Nationwide Shipping of Minoxidil Begins; Company Implements a Varied Branding Strategy.
Next Article:RE: Maritime Electric Co. Limited - First Quarter Results - 1996.
Topics:



Related Articles
Medis El Ltd. issues 1995 second quarter results.
Medis El Ltd. announces new CellScan applications in cancer and autoimmune disease.
Medis El issues 1996 first quarter results.
Medis El issues 1996 second quarter results.
Medis El Ltd. sells shares to a distributor's affiliate.
Corporate Profile for Medis El, dated Jan. 10, 1997.
Medis El Licensed For Important Patent For Its Innovative High-Efficiency Linear Compressor Motor.
Medis El issues 1996 year-end results.
Corporate Profile for Medis El, dated June 13, 1997.
Medis El Ltd. Issues 1998 First Quarter Results.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles